TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
RIGL

Rigel Pharmaceuticals Inc

Healthcare · Biotechnology

48.20$ +0.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Rigel Pharmaceuticals Inc (RIGL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 521 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RIGL
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
89 78 101 85 71 119 99 141 123 139 173 156 156 148 143 138 123 110 216 202 187 167 149 128 116 134 124 117 115 117 127 128 139 164 176 207 243 514 505 521
87 76 100 84 70 117 97 139 121 137 139 125 126 119 116 113 100 89 197 184 171 154 139 121 110 116 107 101 95 99 92 95 106 135 147 175 215 240 234 186
26 18 40 33 26 38 40 65 61 76 75 44 39 23 45 36 37 30 20 85 30 19 25 27 30 24 40 49 45 33 26 36 52 57 46 53 49 41 24 61
85 75 98 82 68 116 94 135 116 129 128 112 107 98 96 92 73 57 39 153 143 125 108 89 82 58 59 64 62 57 50 49 61 77 77 108 137 155 147 95
– – – – – – – 1.6 3.3 4.1 5.6 6.9 12 10 9.7 12 15 16 142 17 15 15 15 17 16 40 29 21 24 31 28 29 31 42 42 40 46 52 50 56
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.9 1.1 1.2 1.2 1.4 1.6 1.7 2.1 1.6 6.9 6.8 7.0 6.6 6.8 6.2 7.1 9.1 11 11 6.1 5.5 6.6 8.1 4.8 6.0 4.7 10 21 12 12 14
1.3 1.2 1.1 1.0 0.9 0.9 1.4 1.5 1.5 1.4 1.6 1.5 1.7 2.2 2.6 2.4 2.5 2.7 2.5 17 14 12 2.1 1.8 1.7 0.9 0.3 0.2 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – 15 15 14 14 14 29 28 28 27 27 26 25 25 24 94
23 23 17 16 15 18 19 18 20 29 77 78 87 94 65 75 72 76 138 133 137 137 142 132 135 148 148 145 147 146 158 158 154 161 157 125 125 122 105 95
21 23 17 16 15 18 19 17 20 28 26 28 31 58 31 35 34 41 52 60 59 64 59 55 47 65 46 44 48 53 73 59 54 63 67 87 94 99 89 95
3.2 3.2 3.1 2.2 1.2 0.3 – – – – 6.8 7.0 7.3 7.3 7.8 8.1 8.3 8.6 8.9 9.2 9.6 9.9 8.3 5.8 3.3 1.1 0.4 0.5 0.7 7.9 15 0.6 0.5 7.6 15 23 30 30 31 40
1.5 5.6 1.2 2.1 2.2 2.6 2.6 3.3 2.6 6.4 1.2 3.8 2.7 4.2 2.2 3.4 2.3 3.7 5.1 1.7 3.1 3.8 4.6 2.2 2.7 23 6.3 5.2 8.0 7.1 9.3 6.1 3.8 3.3 4.0 7.3 3.8 7.2 4.5 4.0
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 25 – 9.8 9.8 9.8 20 20 20 20 20 20 20 30 30 39 39 59 60 60 52 45 60 60 52 45 37 30 22 15 –
66 55 84 70 56 101 80 124 103 110 95 78 69 54 78 63 51 34 78 68 50 30 6.8 -3.7 -20 -14 -24 -28 -32 -29 -32 -30 -15 3.3 19 82 118 391 400 425
-1,045 -1,061 -1,076 -1,095 -1,113 -1,139 -1,163 -1,189 -1,213 -1,209 -1,227 -1,248 -1,259 -1,276 -1,255 -1,273 -1,287 -1,306 -1,266 -1,280 -1,301 -1,324 -1,351 -1,365 -1,384 -1,382 -1,396 -1,403 -1,408 -1,408 -1,416 -1,417 -1,404 -1,390 -1,379 -1,319 -1,291 -1,023 -1,014 -997
9.5 9.9 11 12 12 14 15 16 17 17 17 17 17 17 17 17 17 17 18 17 17 17 17 17 17 17 17 17 17 17 18 18 18 18 18 18 19 19 20 20

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?